IP Library › Granted Patent US 12,478,505
Granted Patent B2
US 12,478,505 · App. 17/126,941 · Granted Nov 25, 2025

Visualization and treatment of media opacity in eye

Inventor: Steven T. Charles (Memphis, TN)
Assignee: Alcon Inc.
A61F9/00825A61B3/10G02B27/286A61F2009/00874
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,478,505
App. No.
17/126,941
Granted
Nov 25, 2025
Kind
B2
Abstract

A system for treating a media opacity in a vitreous media of an eye includes a visualization module adapted to provide visualization data of a portion of the eye via one or more viewing beams. The system includes a laser module adapted to selectively generate a treatment beam directed towards the media opacity in order to disrupt the media opacity. The laser module and the visualization module have a shared aperture for guiding the treatment beam and the one or more viewing beams towards the eye, the shared aperture being centered about a central axis. A controller is configured to acquire one or more defining parameters of the media opacity and determine when the media opacity is with a predefined target zone of a real-time viewing window. The media opacity is treated with the treatment beam when the media opacity is within the predefined target zone.

Claims (50)

1 . A system for treating a media opacity in a vitreous media of an eye, the system comprising:

a visualization module adapted to provide visualization data of a portion of the eye via one or more viewing beams;

a laser module adapted to selectively generate a treatment beam directed towards the media opacity in order to disrupt the media opacity;

wherein the laser module and the visualization module have a shared aperture for guiding the treatment beam and the one or more viewing beams towards the eye, the shared aperture being centered about a central axis;

a controller in communication with the visualization module and the laser module, the controller having a processor and a tangible, non-transitory memory on which instructions are recorded; and

wherein execution of the instructions by the processor causes the controller to acquire one or more defining parameters of the media opacity based at least partially on the visualization data, the one or more defining parameters including a shape and a size of the media opacity; and

wherein the controller is further configured to:

prior to acquiring the one or more defining parameters of the media opacity, define a predefined target zone of a real-time viewing window of the visualization module, the predefined target zone being smaller than the real-time viewing window;

determine when a threshold portion of the media opacity has not moved from the predefined target zone based at least partially on the one or more defining parameters; and

in response to determining when a threshold portion of the media opacity has not moved from a predefined target zone, direct the treatment beam towards the media opacity in the predefined target zone.

2 . The system of claim 1 , further comprising:

a sensor in communication with the controller and configured to detect motion of a patient; and

wherein the controller is configured to disable the treatment beam when motion of the patient is detected by the sensor.

3 . The system of claim 1 , wherein the controller is configured to obtain a speckle pattern of scattered light originating from the treatment beam, the scattered light being sized at about a wavelength of the treatment beam.

4 . The system of claim 1 , wherein the one or more defining parameters include a depth of the media opacity.

5 . The system of claim 1 , further comprising:

a joystick unit in communication with the controller; and

wherein the joystick unit is configured to enable depth selection of the visualization module.

6 . The system of claim 1 , wherein the treatment beam includes a plurality of ultra-short laser pulses.

7 . The system of claim 6 , wherein the plurality of ultra-short laser pulses defines a respective time duration of between about a femtosecond and about 50 picoseconds.

8 . The system of claim 1 , wherein the treatment beam travels in a direction parallel to the central axis.

9 . The system of claim 1 , wherein the treatment beam travels at an off-axis angle from the central axis, the off-axis angle being at or above 25 degrees.

10 . The system of claim 1 , further comprising:

a corneal interfacing member positioned in close proximity to a cornea of the eye, the corneal interfacing member being configured to decrease a depth of field for the treatment beam.

11 . The system of claim 1 , wherein:

the visualization module is configured to employ electromagnetic radiation reflected from one or more optical devices prior to striking the eye, the one or more optical devices being positioned such that only oblique rays strike the eye and central rays are blocked.

12 . The system of claim 1 , wherein:

the visualization module includes a light source, a mirror unit, a first polarizer and a second polarizer, the second polarizer being oriented at 90 degrees with respect to the first polarizer;

the first polarizer is adapted to polarize at least one incident beam from the light source to produce a linearly polarized light wave; and

the mirror unit is adapted to direct the linearly polarized light wave onto the eye; and

the second polarizer is positioned such that a reflected beam exiting the eye is projected onto the second polarizer.

13 . The system of claim 12 , wherein the visualization module further includes:

a birefringent prism configured to intercept the linearly polarized light wave prior to the linearly polarized light wave striking the eye, the birefringent prism being configured to intercept the reflected beam prior to the reflected beam being projected onto the second polarizer.

14 . The system of claim 1 , wherein the visualization module includes an electronically controlled liquid lens having a response time of between 1 and 5 milliseconds.

15 . The system of claim 1 , further comprising:

a wavefront sensor configured to determine ocular aberrations in the one or more viewing beams exiting the eye; and

a deformable mirror configured to shape a wavefront of the treatment beam based in part on the ocular aberrations determined by the wavefront sensor.

16 . The system of claim 1 , further comprising:

a spatial light modulator adapted for shaping at least one of a respective phase and a respective amplitude of the one or more viewing beams, the spatial light modulator being located coaxial to the central axis.

17 . The system of claim 1 , further comprising:

a spatial light modulator adapted for shaping at least one of a respective phase and a respective amplitude of the one or more viewing beams, the spatial light modulator being rotatable off-axis relative to the central axis.

18 . The system of claim 1 , wherein the threshold portion includes 50%.

19 . A method for treating a media opacity in an eye with a system having a visualization module, a laser module and a controller with a processor and a tangible, non- transitory memory on which instructions are recorded, the method comprising:

adapting the laser module to selectively generate a treatment beam directed towards the media opacity;

obtaining visualization data of the eye, via the visualization module;

acquiring and storing one or more defining parameters of the media opacity based at least partially on the visualization data, the one or more defining parameters including a shape and a size of the media opacity;

prior to acquiring the one or more defining parameters of the media opacity, defining a predefined target zone of a real-time viewing window of the visualization module, the predefined target zone being smaller than the real-time viewing window;

determining when a threshold portion of the media opacity has not moved from the predefined target zone based at least partially on the one or more defining parameters, via the controller; and

directing the treatment beam towards the media opacity when the threshold portion of the media opacity has been determined to have not moved from the predefined target zone, via the laser module, in order to disrupt the media opacity.

20 . The method of claim 19 , wherein the threshold portion includes 50%.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2021
From: CHARLES, STEVEN T.
To: ALCON RESEARCH, LLC
Reel/Frame 055744/0772 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2021
From: ALCON RESEARCH, LLC
To: ALCON INC.
Reel/Frame 055744/0787 →
Continuity (3)
Provisional Application 63076942 · Sep 11, 2020
Provisional Application 63059399 · Jul 31, 2020
Related Publication 20220031511A1 · Feb 3, 2022
References Cited (207)
US 3780979A · De Guillebon · 1973 [cited by applicant]
US 4357088A · Pomerantzeff · 1982 [cited by applicant]
US 5312396A · Feld · 1994 [cited by applicant]
US 5909270A · Moser · 1999 [cited by examiner]
US 6142630A · Koester · 2000 [cited by applicant]
US 6322556B1 · Gwon · 2001 [cited by applicant]
US 6789900B2 · Van De Velde · 2004 [cited by applicant]
US 7374287B2 · Van De Velde · 2008 [cited by applicant]
US 7510282B2 · Ueno · 2009 [cited by applicant]
US 7520613B2 · Saito · 2009 [cited by examiner]
US 7703922B2 · Van De Velde · 2010 [cited by applicant]
US 8480659B2 · Frey et al. · 2013 [cited by applicant]
US 8652602B1 · Dolla · 2014 [cited by applicant]
US 8783868B2 · Qiu · 2014 [cited by applicant]
US 8876808B2 · Feklistov et al. · 2014 [cited by applicant]
US 8994753B2 · Nakano · 2015 [cited by applicant]
US 9033500B2 · Utsunomiya · 2015 [cited by applicant]
US 9603519B2 · Bor et al. · 2017 [cited by applicant]
US 9675243B2 · Sasak et al. · 2017 [cited by applicant]
US 9789002B2 · Van De Velde · 2017 [cited by applicant]
US 10130511B2 · Dantus · 2018 [cited by examiner]
US 10478342B2 · Dick · 2019 [cited by examiner]
US 10555835B2 · Schuele · 2020 [cited by examiner]
US 20070258094A1 · Izatt et al. · 2007 [cited by applicant]
US 20070291277A1 · Everett · 2007 [cited by applicant]
US 20090073384A1 · Warden · 2009 [cited by applicant]
US 20090137989A1 · Kataoka · 2009 [cited by applicant]
US 20090196477A1 · Cense et al. · 2009 [cited by applicant]
US 20100123873A1 · Raymond · 2010 [cited by applicant]
US 20100152847A1 · Padrick · 2010 [cited by applicant]
US 20110077557A1 · Wing et al. · 2011 [cited by applicant]
US 20120281235A1 · Murata · 2012 [cited by applicant]
US 20130131652A1 · Dick · 2013 [cited by applicant]
US 20130173029A1 · Caldeira et al. · 2013 [cited by applicant]
US 20140216468A1 · Goldshleger · 2014 [cited by applicant]
US 20140257257A1 · Grant · 2014 [cited by examiner]
US 20140268036A1 · Ketterling et al. · 2014 [cited by applicant]
US 20140276674A1 · Lee · 2014 [cited by applicant]
US 20150190278A1 · Gooding · 2015 [cited by examiner]
US 20150342782A1 · Mordaunt · 2015 [cited by applicant]
US 20160058617A1 · Luttrull et al. · 2016 [cited by applicant]
US 20160074214A1 · Palanker · 2016 [cited by examiner]
US 20160074221A1 · Tassignon et al. · 2016 [cited by applicant]
US 20160166431A1 · Vogler et al. · 2016 [cited by applicant]
US 20160227999A1 · An et al. · 2016 [cited by applicant]
US 20160235588A1 · Hart et al. · 2016 [cited by applicant]
US 20160256324A1 · Suzuki · 2016 [cited by applicant]
US 20160278629A1 · Schuele · 2016 [cited by applicant]
US 20160302969A1 · Yamamoto · 2016 [cited by applicant]
US 20170181625A1 · Kawakami et al. · 2017 [cited by applicant]
US 20170252213A1 · Furuuchi et al. · 2017 [cited by applicant]
US 20170326003A1 · Schuele et al. · 2017 [cited by applicant]
US 20180028354A1 · Heeren · 2018 [cited by applicant]
US 20180028355A1 · Raksi · 2018 [cited by applicant]
US 20180140257A1 · Govindjee et al. · 2018 [cited by applicant]
US 20180206719A1 · Adler et al. · 2018 [cited by applicant]
US 20180317767A1 · Ryan · 2018 [cited by applicant]
US 20180353064A1 · Soetikno et al. · 2018 [cited by applicant]
US 20180368915A1 · Xia et al. · 2018 [cited by applicant]
US 20190159933A1 · Romano et al. · 2019 [cited by applicant]
US 20190282403A1 · Barrett et al. · 2019 [cited by applicant]
US 20190290124A1 · Laforest et al. · 2019 [cited by applicant]
US 20190313903A1 · Mckinnon · 2019 [cited by applicant]
US 20190365569A1 · Skovgaard · 2019 [cited by applicant]
US 20200038241A1 · Wang et al. · 2020 [cited by applicant]
US 20200060873A1 · Heeren · 2020 [cited by applicant]
US 20200085292A1 · Fukuma · 2020 [cited by examiner]
US 20200129336A1 · Schuele et al. · 2020 [cited by applicant]
US 20200130103A1 · Choi · 2020 [cited by applicant]
US 20200192080A1 · Karam · 2020 [cited by examiner]
US 20200196853A1 · Van Hemert et al. · 2020 [cited by applicant]
US 20200273218A1 · Camino et al. · 2020 [cited by applicant]
US 20200397289A1 · Ralston · 2020 [cited by applicant]
US 20200400422A1 · Ralston · 2020 [cited by applicant]
US 20210100450A1 · Amma · 2021 [cited by applicant]
US 20210186753A1 · Al-qaisi et al. · 2021 [cited by applicant]
US 20210275009A1 · Yates · 2021 [cited by applicant]
US 20210378507A1 · Wallace · 2021 [cited by applicant]
US 20210386586A1 · Bor · 2021 [cited by applicant]
US 20220012459A1 · Schwiegerling · 2022 [cited by applicant]
US 20220031511A1 · Charles · 2022 [cited by applicant]
US 20230157889A1 · Bor · 2023 [cited by applicant]
AU 2018274939B2 · 2020 [cited by examiner]
CN 210009227U · 2020 [cited by applicant]
CN 108371542B · 2020 [cited by applicant]
CN 109196333B · 2020 [cited by applicant]
CN 111281651B · 2020 [cited by applicant]
CN 112862782A · 2021 [cited by applicant]
CN 112587302B · 2021 [cited by applicant]
CN 112587304B · 2021 [cited by applicant]
DE 19705044A1 · 1998 [cited by applicant]
DE 102019007147A1 · 2021 [cited by applicant]
DE 102019007148A1 · 2021 [cited by applicant]
EP 0770370A2 · 1997 [cited by applicant]
EP 1212022B1 · 2005 [cited by applicant]
EP 1563785A1 · 2005 [cited by applicant]
EP 1638452B1 · 2006 [cited by applicant]
EP 1838212A1 · 2007 [cited by applicant]
EP 2144552A1 · 2010 [cited by applicant]
EP 1928297B1 · 2010 [cited by applicant]
EP 2459138A2 · 2012 [cited by applicant]
EP 2525706A2 · 2012 [cited by applicant]
EP 2898820A1 · 2015 [cited by applicant]
EP 3061429A1 · 2016 [cited by applicant]
EP 2890340B1 · 2017 [cited by applicant]
EP 3459487A1 · 2019 [cited by applicant]
EP 3501463A1 · 2019 [cited by applicant]
EP 3636137A1 · 2020 [cited by applicant]
EP 3861924A1 · 2021 [cited by applicant]
GB 2469249A · 2010 [cited by applicant]
JP 2000350742A · 2000 [cited by applicant]
JP 2015093169A · 2015 [cited by applicant]
JP 5767014B2 · 2015 [cited by applicant]
JP 2017176558A · 2017 [cited by applicant]
JP 6410468B2 · 2018 [cited by applicant]
JP 2018196821A · 2018 [cited by applicant]
JP 2018196822A · 2018 [cited by applicant]
JP 2019010132A · 2019 [cited by applicant]
JP 2020022569A · 2020 [cited by applicant]
JP 6736304B2 · 2020 [cited by applicant]
JP 6839902B2 · 2021 [cited by applicant]
RU 2661016C1 · 2018 [cited by applicant]
RU 2692666C1 · 2019 [cited by applicant]
RU 2695629C1 · 2019 [cited by applicant]
RU 2710058C2 · 2019 [cited by applicant]
RU 2726468C1 · 2020 [cited by applicant]
WO 9958047A1 · 1999 [cited by applicant]
WO 0137769A1 · 2001 [cited by applicant]
WO 0195791A1 · 2001 [cited by applicant]
WO 2007059189A2 · 2007 [cited by applicant]
WO 2009033110A2 · 2009 [cited by applicant]
WO 2009036104A2 · 2009 [cited by applicant]
WO 2009039315A2 · 2009 [cited by applicant]
WO 2009059400A1 · 2009 [cited by applicant]
WO 2010117386A1 · 2010 [cited by applicant]
WO 2014053824A1 · 2014 [cited by applicant]
WO 2015131135A1 · 2015 [cited by applicant]
WO 2015171793A1 · 2015 [cited by applicant]
WO 2016033590A1 · 2016 [cited by applicant]
WO 2017062673A1 · 2017 [cited by applicant]
WO 2017196306A1 · 2017 [cited by applicant]
WO 2017205857A1 · 2017 [cited by applicant]
WO 2020074532A1 · 2020 [cited by applicant]
WO 2020180729A1 · 2020 [cited by applicant]
WO 2020215359A1 · 2020 [cited by applicant]
WO 2020216763A1 · 2020 [cited by applicant]
WO 2020257711A1 · 2020 [cited by applicant]
WO 2021023799A1 · 2021 [cited by applicant]
WO 2021049243A1 · 2021 [cited by applicant]
WO 2021066047A1 · 2021 [cited by applicant]
WO 2021092211A1 · 2021 [cited by applicant]
WO 2021183637A1 · 2021 [cited by applicant]
WO 2022149028A1 · 2022 [cited by applicant]
WO 2023089416A1 · 2023 [cited by applicant]
WO 2023089459A1 · 2023 [cited by applicant]
WO 2023097391A1 · 2023 [cited by applicant]
Mojana F, Kozak I, Oster SF, Cheng L, Bartsch DU, Brar M, Yuson RM, Freeman WR. Observations by spectral-domain optical coherence tomography combined with simultaneous scanning laser ophthalmoscopy: imaging of the vitre… [cited by examiner]
Chi-Hung Lee et al. Imaging vitreous floaters and cataracts with optical simulations, Optik, vol. 194, 2019, 163075, ISSN 0030-4026. (Year: 2019). [cited by examiner]
Jihwan Kim, et al., Nonmechanical Laser Beam Steering Based on Polymer Polarization Gratings: Design Optimization and Demonstration, Journal of Lightwave Technology, May 15, 2015, 2068-2077, 33-10, IEEE. [cited by applicant]
Michael J. Escuti, et al., Geometric-Phase Holograms, Optics & Photonics News, Feb. 22-29, 2016, 1047-6938/16/02/22/8. [cited by applicant]
Blake F. Webb, et al.; “Prevalence of vitreous floaters in a community sample of smartphone users”; Internat'l Journal of Ophthalmology; Jun. 18, 2013; pp. 402-405; 6(3); PMC/ US National Library of Medicine National In… [cited by applicant]
Chirag P. Shah, et al., YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters A Randomized Clinical Trial, JAMA Ophthalmology, Sep. 2017, 918-923, 135-9. [cited by applicant]
Damodaran et al., “Digital micromirror device based ophthalmoscope with concentric circle scanning”, 2017, pp. 2766-2780, vol. 8, No. 5, Biomedical Optics Express. [cited by applicant]
ELLEX Website, Treatment Guidelines—Laser Floater Removal; 2016, Ellex Medical Pty Ltd. E&OE. VB0002E, downloaded Apr. 20, 2017. [cited by applicant]
Felix Sauvage et al: “Photoablation of Human Vitreous Opacities by Light—Induced Vapor Nanobubbles”, ACS Nano, vol. 13, No. 7, Jul. 9, 2019, pp. 8401-8416. [cited by applicant]
Fischer et al., “Scanning Laser Ophthalmoscopy (SLO)”, In: Bille JF, editor. High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics [Internet], Aug. 14, 2019, accessed on Jan. 30, 20… [cited by applicant]
Ginner et al., “Wide-Field OCT Angiography at 400 KHz Utilizing Spectral Splitting”, Photonics, Oct. 23, 2014, pp. 369-379, vol. 1, No. 4. [cited by applicant]
Heidelberg Engineering Gmbh, “Spectralis. Hardware Operating Instructions,” Version 001, Aug. 2007. [cited by applicant]
Heidelberg Engineering, “Spectralis. Multimodal Imaging Platform Optimized for the Posterior Segment”, accessed on Jan. 30, 2023 from https://business-lounge.heidelbergengineering.com/us/en/products/spectralis/spectrali… [cited by applicant]
Hofer et al., “Dispersion encoded full range frequency domain optical coherence tomography”, Jan. 5, 2009, pp. 7-24, vol. 17, No. 1, Optics Express, US. [cited by applicant]
Hofer et al., “Fast dispersion encoded full range optical coherence tomography for retinal imaging at 800 nm and 1060 nm”, Mar. 1, 2010, pp. 4898-4919, vol. 18, No. 5, Optics Express. [cited by applicant]
Leitgeb et al., “Complex ambiguity-free Fourier domain optical coherence tomography through transverse scanning”, 2007, pp. 3453-3455, vol. 32, Optics Letters. [cited by applicant]
Li et al., “DMD-based three-dimensional chromatic confocal microscopy”, 2020, pp. 4349-4356, vol. 59, No. 14, Applied Optics. [cited by applicant]
Martial et al., “Programmable Illumination and High-Speed, Multi- Wavelength, Confocal Microscopy Using a Digital Micromirror”, Aug. 2012, e43942, vol. 7, No. 8, Plos One. [cited by applicant]
Milston Rebecca et al: “Vitreous floaters: Etiology, diagnostics, and management”, Survey of Ophthalmology, vol. 61, No. 2, Mar. 1, 2016, pp. 211-227. [cited by applicant]
Nicusor Iftimia et al: “Hybrid retinal imaginer using line-scanning laser ophthalmoscopy and spectral domain optical coherence tomography”, Optics Express, vol. 14, No. 26, Dec. 22, 2006. [cited by applicant]
Reece Bergstrom, et al., Vitreous Floaters, National Center for Biotechnology Information, May 21, 2020, 4 pages, Bookshelf ID NBK470420, StatPearls Publishing LLC, online. [cited by applicant]
Reznicek Lukas et al., “Wide-Field Megahertz OCT Imaging of Patients with Diabetic Retinopathy”, Journal of Diabetes Research, 2015, 5 pages. [cited by applicant]
Ruggeri et al., “Imaging and full-length biometry of the eye during accommodation using spectral domain OCT with an optical switch”, Jul. 1, 2012, pp. 1506-1520, vol. 3, No. 7, Biomedical Optics Express. [cited by applicant]
Sarunic et al., “Instantaneous complex conjugate resolved spectral domain and swept-source OCT using 3×3 fiber couplers”, Feb. 2005, pp. 957-967, vol. 13, No. 3, Optics Express. [cited by applicant]
Singh, “Lasers Take Aim At Floaters”, Ophthalmology Management, Jul. 1, 2019, pp. 38, 40-42, 59, vol. 23. [cited by applicant]
Singh, “Modern vitreolysis—YAG laser treatment now a real solution for the treatment of symptomatic floaters”, Survey of Ophthalmology, Mar. 3, 2020, pp. 581-591, vol. 65, No. 5. [cited by applicant]
Wang et al., “In vivo full range complex Fourier domain optical coherence tomography”, Jan. 30, 2007, 054103, vol. 90, Applied Physics Letters. [cited by applicant]
Wikipedia Encyclopedia, Floater, Wikipedia Encyclopedia, Mar. 29, 2021, online: https://en.wikipedia.org/wiki/rloater?wprov=sfti 1. [cited by applicant]
Wojtkowski et al., “Full range complex spectral optical coherence tomography technique in eye imaging”, 2002, pp. 1415-1417, vol. 27, No. 16, Optics Letters. [cited by applicant]
Yasuno et al., “Simultaneous B—M-mode scanning method for real-time full-range Fourier domain optical coherence tomography”, 2006, pp. 1861-1865, vol. 45, No. 8, Applied Optics. [cited by applicant]
Zhang et al., Removal of a mirror image and enhancement of the signal-to-noise ratio in Fourier-domain optical coherence tomography using an electro-optic phase modulator, Jan. 15, 2005, vol. 30, No. 2, Optics Letters. [cited by applicant]
Zhang Yunbo et al: “Parallel large-range scanning confocal microscope based on a digital micromirror device”, Optik vol. 124, No. 13 (2013), Aug. 4, 2012, pp. 1585-1588. [cited by applicant]
Zhou et al., “Dual channel dual focus optical coherence tomography for imaging accommodation of the eye”, May 25, 2009, pp. 8947-8955, vol. 17, No. 11, Optics Express. [cited by applicant]
Carol L. Shields et al, “Wide-angle Imaging Of the Ocular Fundus”, Review of Ophthalmology, published Feb. 15, 2003. [cited by applicant]
SunLED, NanoPoint-0201 Series LEDs, published Feb. 15, 2016. [cited by applicant]
Volk Idrees Mid-Vitreous-Volk Optical, Dec. 20, 2020, https://www.volk.com/ . . . s?pr_prod_strat=collection_fallback&pr_rec_pid=4513049018402&pr_ref_pid=4513048952866&pr_seq=uniform [Dec. 20, 2020 11:05:28 AM]. [cited by applicant]
Volk Singh Mid-Vitreous Lens-Volk Optical, Dec. 20, 2020, https://www.volk.com/products/singh-mid-vitreous-vitreous-slit-lamp-lens?_pos=3&_sid=b50c0674f&_ss=r[Dec. 20, 2020 11:04:54 AM]. [cited by applicant]
Adrian G.H. Podoleanu et al., Combined optical coherence tomograph and scanning laser ophthalmoscope mi nije dostupan besplatno., Electronics Letters, 34 (11), 1998. [cited by applicant]
Christy K. Sheehy et al., High-speed, image-based eye tracking with a scanning laser ophthalmoscope, Biomedical Optics Express, vol. 3, No. 10, 2012. [cited by applicant]
D. H. Kelly, “Retinal Inhomogeneity. II. Spatial Summation,” J. Opt. Soc. Am., pp. 114-119, vol. 1, No. 1 (Jan. 1984). [cited by applicant]
D. H. Kelly, “Retinal Inhomogeneity. III. Circular-Retina Theory,” D.H. Kelly, J. Opt. Soc. Am., pp. 810-819, vol. 2, No. 6 (Jun. 1985). [cited by applicant]
D.H. Kelly, “Visual Processing of Moving Stimuli,” J. Opt. Soc. Am., pp. 216-225, vol. 2, No. 2 (Feb. 1985). [cited by applicant]
D.H. Kelly,, “Motion and Vision. II. Stabilized Spatio-Temporal Threshold Surface,” J. Opt. Soc. Am., pp. 1340-1349, vol. 69, No. 10 (Oct. 1979). [cited by applicant]
D.H.Kelly, “Retinal Inhomogeneity. I. Spatiotemporal Contrast Sensitivity,” J. Opt. Sec. Am., pp. 107-113, vol. 1, No. 1 (Jan. 1984). [cited by applicant]
Nidek, Scanning Laser Ophthalmoscope Mirante SLO/OCT Mirante SLO, https://www.nidek-intl.com/product/ophthaloptom/diagnostic/dia_retina/mirante.htm. [cited by applicant]
Peter G. J. Barten, “Contrast Sensitivity of the Human Eye and its Effects on Image Quality,” Chapter 3, pp. 27-40, Model for the spatial contrast sensitivity of the eye, (1999). [cited by applicant]
Pointer, J. S., & Hess, R. F. “The contrast sensitivity gradient across the human visual field: With emphasis on the low spatial frequency range,”, R. F. Vision Research, 29(9), 1133-1151 (1989). [cited by applicant]
Sebag J et al., Vitreous and Vitreoretinal Interface, Ch. 21, 2015. [cited by applicant]
Sebag J., Vitreous and Vision Degrading Myodesopsia. Progress in Retinal and Eye Research Nov. 2020;79. [cited by applicant]
T Ivanova et al., Vitrectomy for primary symptomatic vitreous opacities: an evidence-based review, Eye (Lond) May 2016;30(5):645-55. [cited by applicant]
Teri T Kleinberg et al., Vitreous substitutes: a comprehensive review, Survey of Ophthalmology, 56 (4), 2011. [cited by applicant]